Skip to main
SIBN
SIBN logo

SI-BONE Inc (SIBN) Stock Forecast & Price Target

SI-BONE Inc (SIBN) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 40%
Buy 60%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

SI-BONE Inc reported a significant increase in gross margin, rising approximately 80 basis points year-over-year to reach 79.8% in the second quarter of 2025, indicating improved profitability. Revenue growth was robust, with a year-over-year increase of around 23%, totaling $46.4 million, which reflects strong demand for the company's innovative surgical implant products. Additionally, the company experienced a notable expansion in its surgeon base, with a 25% increase in surgeons using its products and a corresponding rise in production by its sales representatives, contributing to overall sales momentum.

Bears say

The financial outlook for SI-BONE Inc. is negatively influenced by persistent pricing and procedure headwinds in the global spine market, which have resulted in overall growth rates slowing to the low-single digits. Additionally, the potential for payors to favor reimbursement for competitive products poses a significant risk, as this could lead to a decline in SI-BONE's market share within the sacroiliac joint fusion segment, adversely impacting the company's top-line revenue. Most industry players anticipate that these headwinds will continue, further depressing overall market growth and raising concerns about SI-BONE's future financial performance.

SI-BONE Inc (SIBN) has been analyzed by 5 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 60% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SI-BONE Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SI-BONE Inc (SIBN) Forecast

Analysts have given SI-BONE Inc (SIBN) a Buy based on their latest research and market trends.

According to 5 analysts, SI-BONE Inc (SIBN) has a Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $24.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $24.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SI-BONE Inc (SIBN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.